Alex Sapir, Founder of ReViral

Alex Sapir is the founder of ReViral. ReViral has raised $154M in total funding. Latest round: IPO. Based in UK.

About Alex Sapir

Alex Sapir serves as the CEO of ReViral, a UK-based clinical-stage biotechnology company focused on developing antiviral compounds for respiratory syncytial virus (RSV). Before joining ReViral, he held leadership positions at Dova Pharmaceuticals and was the Chief Executive at Fulcrum Therapeutics.

Alex Sapir at a glance

More founders in UK (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library